SOURCE: Patheon


October 05, 2015 09:00 ET

Patheon to Highlight Flexible Capacity Solutions and Solubilization at CPhI/ICSE Worldwide 2015

Patheon's Marshall Crew, Ph.D., and Joe Principe to Present in the Speaker's Corner on Oct. 14

DURHAM, NC--(Marketwired - October 05, 2015) - Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma industries, will be on site at the 26th Annual CPhI/ICSE Worldwide conference from , Oct. 13 - Oct. 15, in Madrid.

Two noted Patheon experts will present at the Speaker's Corner on Wednesday, Oct. 14.

At noon, Marshall Crew, Ph.D. and vice president, global PDS scientific excellence, will discuss how to optimize solubilization strategies and unlock the potential of promising drugs in his presentation, "The Story of Solubilization: New Data and Insights on the Past and What Lies Ahead." Low solubility is a growing issue in the successful development of pharmaceutical products, and solubility outcomes can be unpredictable. Crew will explore the scientific expertise that is required to ensure success for these increasingly complex formulations, and the multiple technologies available to address solubility.

In addition, Joe Principe, vice president of global alliance accounts, will present "Mitigating Uncertainty in Demand Forecasting with Flexible Capacity Solutions" at 2:30 p.m. Pharmaceutical companies develop forecasts to estimate future needs, but predicting performance in a market filled with competing products that do not yet exist is problematic. Principe will discuss several ways to provide cost-effective flexible manufacturing capacity.

Patheon executives, technical and scientific experts attending CPhI/ICSE Worldwide will be available to discuss the company's full services and capabilities. Representatives can be found at booth #3F10 for the duration of the conference. To schedule a meeting in advance, please email

For more information on upcoming events, visit

About Patheon
Patheon is a leading global provider of outsourced pharmaceutical development and manufacturing services. With approximately 8,700 employees worldwide, Patheon provides a comprehensive, integrated and highly customizable set of solutions to help customers of all sizes satisfy complex development and manufacturing needs at any stage of the pharmaceutical development cycle.

Contact Information